Loading clinical trials...

Naxitamab and GM-CSF in People With Neuroblastoma | Clinical Trials | Clareo Health

No Longer AvailableNCT04501757

Naxitamab and GM-CSF in People With Neuroblastoma

This is an Expanded Access Program (EAP) that will give the participants access to the drug naxitamab before it is approved by the FDA. Naxitamab will be combined with granulocyte-macrophage colony st...

Lead sponsor: Memorial Sloan Kettering Cancer Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

NCT06057948 · Neuroblastoma, High-risk Neuroblastoma, and more

COMPLETEDPhase 1

Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma

NCT05373901 · High-risk Neuroblastoma

WITHDRAWNNA

PediCARE Health Equity Intervention in High-Risk Neuroblastoma

NCT06335745 · Neuroblastoma, High-risk Neuroblastoma, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 8, 2022Terms

Trial snapshot

StatusNO_LONGER_AVAILABLE

Phase—

Enrollment—

Start date—

Last updatedDec 8, 2022

Condition

High-Risk Neuroblastoma

Locations shown

Memorial Sloan Kettering Cancer Center

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions